Lovell Stephanie

DirectorTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$178K
Net Open-Market Flow
-$178K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)1K$149.62$178K3K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-097058) within minutes of acceptance. Every field above traces to the original document. Verify it directly: